Predicting prolonged dose titration in patients starting warfarin.

about

Evaluation of CYP2C9- and VKORC1-based pharmacogenetic algorithm for warfarin dose in Gaza-Palestine.

P2860

Q55379283-BBA5C6C5-656E-430F-865A-0157462F1575

P2860

Predicting prolonged dose titration in patients starting warfarin.

Item

http://www.wikidata.org/entity/Q39561868

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Predicting prolonged dose titration in patients starting warfarin.

@en

Predicting prolonged dose titration in patients starting warfarin.

@nl

type

Item

label

Predicting prolonged dose titration in patients starting warfarin.

@en

Predicting prolonged dose titration in patients starting warfarin.

@nl

prefLabel

Predicting prolonged dose titration in patients starting warfarin.

@en

Predicting prolonged dose titration in patients starting warfarin.

@nl

P1476

Predicting prolonged dose titration in patients starting warfarin

@en

P2093

Andrew E Epstein

http://www.w3.org/2001/XMLSchema#string

Benjamin French

http://www.w3.org/2001/XMLSchema#string

Colleen M Brensinger

http://www.w3.org/2001/XMLSchema#string

Luanne Bershaw

http://www.w3.org/2001/XMLSchema#string

Michael B Streiff

http://www.w3.org/2001/XMLSchema#string

Stephen E Kimmel

http://www.w3.org/2001/XMLSchema#string

P2860

Patients' perspectives on taking warfarin: qualitative study in family practice

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets.

Time-dependent ROC curves for censored survival data and a diagnostic marker.

The prediction accuracy of dynamic mixed-effects models in clustered data

Estimation of the warfarin dose with clinical and pharmacogenetic data.

Using relative utility curves to evaluate risk prediction.

Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study

Risk factors for nonadherence to warfarin: results from the IN-RANGE study.

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

P304

1228-1235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.4069

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brian S Finkelman

P577

2016-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27456080

http://www.w3.org/2001/XMLSchema#string

P932

5093054

http://www.w3.org/2001/XMLSchema#string

Predicting prolonged dose titration in patients starting warfarin.

about

P2860

P2860

Predicting prolonged dose titration in patients starting warfarin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932